by Anita Snow This electron microscope image provided by the Centers for Disease Control and Prevention shows a cluster of norovirus virions. Credit: Charles D. Humphrey/CDC via AP, File Cases of a wretched stomach bug are surging in parts of the United States this winter, according to government data. The most recent numbers from the...
Post
FDA approves Ryoncil for steroid-refractory acute graft-versus-host after allo-HSCT
by Elana Gotkine The allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy Ryoncil (remestemcel-L-rknd) has been approved for treatment for steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients aged 2 months or older, according to a press release from the U.S. Food and Drug Administration. Ryoncil is the first FDA-approved MSC therapy. MSCs are isolated...
Post
ADHD drug a promising treatment for methamphetamine dependence
By Paul McClure December 27, 2024 An existing ADHD medication can help people quit methamphetamine Depositphotos View 1 Images New research has found that an existing ADHD medication greatly reduced the number of days people with a methamphetamine dependence used the drug. With no current drug treatment to assist people in getting off meth, the study’s...
Post
Heart Attack, Stroke Survivors at High Risk for Long COVID
Tinker Ready October 14, 2024 8111 Added to Email Alert Primary care doctors and specialists should advise patients who have already experienced a heart attack or stroke that they are at a higher risk for long COVID and need to take steps to avoid contracting the virus, according to new research. The study, led by researchers...
Post
Expert Tips for Managing GLP-1 Medication Side Effects
Sara Novak December 27, 2024 4270 Added to Email Alert Glucagon-like peptide 1 (GLP-1) medications have become a powerful weight loss tool in a country where 40% of the population is obese. Patients taking these medications can experience weight loss, a life changing amount for those who have been struggling with weight and related health...
Post
8 Erectile Dysfunction (ED) Medication Side Effects: Headaches, Flushing, and More
Written by Mandeep Sohal, PharmD | Reviewed by Bailey E. Eason, PharmD, MS, BCPS Published on November 5, 2024print_outlinedemail_outlined Key takeaways: Access savings on related medications info_outlinedPromotional disclosure SildenafilTadalafil CialisVardenafilViagraCialis Table of contents Side effect overview Headaches Flushing Stomach upset Nasal effects Low blood pressure Vision changes Priapism Injection problems Bottom line References GoodRx Health Many men turn...
Post
The Truth About Compounded GLP-1s That Doctors Need to Know
Eldad Einav, MDDisclosures March 26, 2024 50 230 Share Added to Email Alerts As a cardiologist specializing in obesity medicine, I often encounter patients who would greatly benefit from the new generation of weight loss drugs that work as glucagon-like peptide 1 (GLP-1) agonists. In the recently published SELECT trial results, for example, semaglutide (marketed by Novo Nordisk as Wegovy for weight loss...
Post
7 Foods to Avoid for a Healthy Immune System
Written by Anne Jacobson, MD, MPH | Reviewed by Katie E. Golden, MD Published on April 1, 2024print_outlinedemail_outlined Key takeaways: Table of contents Refined grains Ultra-processed foods Fried foods Salty foods Added sugar Red meat Alcohol Bottom line References Giselleflissak/E+ via Getty Images Your immune system is your body’s built-in protection. When it’s working well, it keeps out most of...
Post
Why Do GLP-1 Drugs Stop Working, and What to Do About It?
Marilynn Larkin January 12, 2024 261185 Added to Email Alert There’s no question that glucagon-like peptide 1 (GLP-1) agonists represent a major advance in the treatment of obesity for patients with or without diabetes. In clinical trials, participants lost 15%-20% of their body weight, depending on the drug. But studies also have shown that once people stop taking these drugs...
Post
Thyroid Warning on GLP-1s Could Raise Overdiagnosis Risk
Kerry Dooley Young July 02, 2024 131323 Added to Email Alert ORLANDO, Florida — Clinicians should keep in mind concerns about overdiagnosis of thyroid cancer when prescribing glucagon-like peptide 1 (GLP-1) drugs, as the US black box warning about this risk for this class of medicines for certain tumors in mice could trigger excess screening,...